Treating chronic limb-threatening ischemia has become a far more individualized process than it was even a decade ago.
As Dr. John Rundback explains, the shift toward BTK-dominant disease, multiple access strategies, and an explosion of device options has made decision-making increasingly nuanced.
And with systems like the Angiodynamics Auryon laser introducing new variables, operators are redefining what “standard of care” looks like in real time.
To hear more of this discussion, go to Life Of Flow’s channel and watch the full episode with Dr. John Rundback.
